June 2026 brought two FDA milestones for pediatric diabetes: an OTC kids’ CGM and teplizumab for Stage 3 Type 1 diabetes in ages 8–17. Here’s what each one does and who qualifies.
June Brought Two Major FDA Advances for Children with Type 1 Diabetes: Here’s What Each One Does
by | Jun 28, 2026 | Uncategorized | 0 comments
Recent Comments